Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
373 studies found for:    Open Studies | "Stomach Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Stomach Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer
Condition: Stomach Neoplasms
Intervention: Biological: EPCAM-targeted CAR-T cells
2 Recruiting Irinotecan as 3rd Line Therapy in Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: Irinotecan
3 Recruiting Treatment Strategy for Stage IV Gastric Cancer With Positive Peritoneal Cytology as the Only Non-curable Factor
Condition: Stomach Neoplasm
Interventions: Procedure: standard gastrectomy with D2 lymphadenectomy;   Procedure: hyperthermic intraperitoneal chemotherapy;   Procedure: Extensive intraperitoneal lavage;   Other: Preoperative chemotherapy;   Other: Postoperative chemotherapy
4 Recruiting Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Procedure: Laparoscopic Spleen-Preserving No.10 Lymph Node Dissections
5 Not yet recruiting Serological Screening of Gastric Cancer in Wuxi Region
Condition: Stomach Neoplasms
Intervention: Device: serological examination and gastroscope
6 Not yet recruiting Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Device: Boston Scientific Large Capacity with needle Biopsy;   Device: Endodrill 1A (BIBBInstruments, Lund, Sweden)
7 Recruiting Lifestyle Intervention for Prevention of Gastric Neoplasm
Condition: Stomach Neoplasms
Intervention: Behavioral: Active measures of lifestyle modification
8 Not yet recruiting ctDNA for Prediction of Relapse in Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Other: ctDNA test
9 Recruiting Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients
Conditions: Stomach Neoplasms;   Gastric Cancer
Interventions: Drug: oxaliplatin;   Drug: etoposide;   Drug: pharmorubicin;   Drug: S-1
10 Not yet recruiting Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer
Conditions: Stomach Neoplasms;   Gastric Cancer
Interventions: Drug: oxaliplatin;   Drug: etoposide;   Drug: epirubicin;   Drug: S1
11 Recruiting Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms
Condition: Stomach Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
12 Recruiting Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: Capecitabine
13 Recruiting Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B Carriers
Condition: Stomach Neoplasms
Intervention: Drug: Entecavir
14 Recruiting Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Other: Quality of life assessment
15 Recruiting Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study
Condition: Gastric Cancer
Interventions: Drug: docetaxel,0xaliplatin,capecitabine;   Drug: oxaliplatin,capecitabine
16 Recruiting Early Onset and Familial Gastric Cancer Registry
Condition: Gastric Cancer
Intervention: Behavioral: questionnaires
17 Recruiting Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients ("EXO-PPP Study")
Condition: Gastric Cancer
Intervention:
18 Recruiting Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: Capecitabine/cisplatin;   Drug: S-1/cisplatin;   Drug: Capecitabine/oxaliplatin;   Drug: 5-fluorouracil/oxaliplatin;   Drug: Capecitabine;   Drug: S-1;   Drug: 5-fluorouracil
19 Recruiting Dovitinib for Gastric Cancer With FGFR2 Amplification
Condition: Gastric Cancer
Intervention: Drug: Dovitinib
20 Recruiting NBI for Identifying Resection Margin Status in Gastric Cancer
Condition: Gastric Cancer
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.